Chantalat, Elodie <br/><br/>
Cervical cancer with paraaortic involvement: do patients truly benefit from tailored chemoradiation therapy? A retrospective study on 8 French centers.  [electronic resource] 

 -  European journal of obstetrics, gynecology, and reproductive biology  Oct 2015 
 - 118-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1872-7654 
<br/><br/><label>Standard No.: </label>10.1016/j.ejogrb.2015.07.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Aorta<br/>Brachytherapy<br/>Carcinoma, Squamous Cell--diagnosis<br/>Chemoradiotherapy--methods<br/>Chemotherapy, Adjuvant<br/>Cisplatin--therapeutic use<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lymph Node Excision<br/>Lymphatic Metastasis<br/>Magnetic Resonance Imaging<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local--pathology<br/>Neoplasm Staging<br/>Positron-Emission Tomography<br/>Retrospective Studies<br/>Survival Rate<br/>Tomography, X-Ray Computed<br/>Uterine Cervical Neoplasms--diagnosis